Alamar Biosciences Reports Q3 2026 Results

What Happened

• On August 10, 2026, Alamar Biosciences, Inc. announced its financial results for the quarter ended June 30, 2026 by issuing a press release. The company furnished the press release as Exhibit 99.1 to an 8‑K under Item 2.02 (Results of Operations and Financial Condition). The filing was signed by Justin McAnear, Chief Financial Officer.

Key Details

• Date of announcement: August 10, 2026.
• Period covered: quarter ended June 30, 2026.
• Disclosure: Press release attached as Exhibit 99.1 and incorporated by reference in the 8‑K.
• Filing sections: Item 2.02 (results furnished) and Item 9.01 (exhibits); signed by CFO Justin McAnear.

Why It Matters

• This 8‑K signals that Alamar has publicly released its quarterly earnings and related financial information — important for assessing recent revenue, expenses, cash position, and any commentary on business trends.
• Retail investors should read the linked press release (Exhibit 99.1) for the specific earnings figures, guidance (if any), and management comments, and monitor the company’s upcoming 10‑Q for the full, audited quarterly report.